Institut Bordet - Retour à la page d'accueil
en
I want to donate to research

Francesco Sclafani

Department : Medical oncology
 
francesco.sclafani [at] bordet.be

Publications

Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer.

Authors : Bregni G, Vandeputte C, Pretta A, Senti C, Trevisi E, Acedo Reina E, Kehagias P, Liberale G, Moretti L, Bali MA, Demetter P, Flamen P, Carrasco J, DHondt L, Geboes K, Gokburun Y, Peeters M, Van den Eynde M, Van Laethem JL, Vergauwe P, Chapot CA, Buyse M, Deleporte A, Hendlisz A, Sclafani F
Year : 2021
Journal : Acta Oncol

Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer.

Authors : Wrona E, Potemski P, Sclafani F, Borowiec M
Year : 2021
Journal : Arch Immunol Ther Exp (Warsz)

Anal squamous cell carcinoma: standards of care, new data and ongoing clinical trials.

Authors : Giunta EF, Bregni G, Hendlisz A, Sclafani F
Year : 2021
Journal : Curr Opin Oncol

Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials.

Authors : Giunta EF, Bregni G, Pretta A, Deleporte A, Liberale G, Bali MA, Moretti L, Troiani T, Ciardiello F, Hendlisz A, Sclafani F
Year : 2021
Journal : Cancer Treat Rev

Radioembolization for metastatic colorectal cancer: towards maturity, at last?

Authors : Hendlisz A, Sclafani F
Year : 2021
Journal : Curr Opin Oncol

More publications »

Follow us!

Youtube

Delivery of the first MRI-Linac in Belgium to the Radiotherapy Department of the New Jules Bordet Institute!

The very latest radiotherapy equipment representing one more step on the road to perfecting our cancer treatment and the precision of our patient care.